StockData
Relay Therapeutics, Inc. logo

Relay Therapeutics, Inc. (RLAY) stock

RLAYNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 10/30
$17.27−0.82 (-4.53%)

Close on Nov 16, 2026Market cap $3.78BP/E –Yield –

Relay Therapeutics cash

Cash and short-term investments held at the end of each period.

Relay Therapeutics's cash was $121.19M at Jun 30, 2026. For fiscal 2025 it was $84.02M, down 33.5% from the year before. The highest annual figure on record is $448.52M in fiscal 2020.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025$84.02M-33.5%
FY2024Dec 31, 2024$126.41M-13.7%
FY2023Dec 31, 2023$146.44M-5.1%
FY2022Dec 31, 2022$154.37M-45.4%
FY2021Dec 31, 2021$282.70M-37.0%
FY2020Dec 31, 2020$448.52M+947.2%
FY2019Dec 31, 2019$42.83M-89.9%
FY2018Dec 31, 2018$422.38M–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$121.19M+6.4%
Q1 FY2026Mar 31, 2026$204.59M+118.7%
Q4 FY2025Dec 31, 2025$84.02M-33.5%
Q3 FY2025Sep 30, 2025$91.56M-39.9%
Q2 FY2025Jun 30, 2025$113.94M-15.0%
Q1 FY2025Mar 31, 2025$93.54M-38.8%
Q4 FY2024Dec 31, 2024$126.41M-13.7%
Q3 FY2024Sep 30, 2024$152.36M+0.7%
Q2 FY2024Jun 30, 2024$134.13M-8.1%
Q1 FY2024Mar 31, 2024$152.87M-5.2%
Q4 FY2023Dec 31, 2023$146.44M-5.1%
Q3 FY2023Sep 30, 2023$151.33M-57.3%
Q2 FY2023Jun 30, 2023$145.90M+35.4%
Q1 FY2023Mar 31, 2023$161.28M+35.0%
Q4 FY2022Dec 31, 2022$154.37M-45.4%
Q3 FY2022Sep 30, 2022$354.64M+55.2%
Q2 FY2022Jun 30, 2022$107.74M-58.6%
Q1 FY2022Mar 31, 2022$119.45M-54.5%
Q4 FY2021Dec 31, 2021$282.70M-37.0%
Q3 FY2021Sep 30, 2021$228.56M-59.1%
Q2 FY2021Jun 30, 2021$260.07M+89.8%
Q1 FY2021Mar 31, 2021$262.72M+273.5%
Q4 FY2020Dec 31, 2020$448.52M+947.2%
Q3 FY2020Sep 30, 2020$559.28M+1825.6%
Q2 FY2020Jun 30, 2020$137.05M+248.2%
Q1 FY2020Mar 31, 2020$70.34M-83.3%
Q4 FY2019Dec 31, 2019$42.83M–
Q3 FY2019Sep 30, 2019$29.05M–
Q2 FY2019Jun 30, 2019$39.36M–
Q4 FY2018Dec 31, 2018$422.38M–

More Relay Therapeutics figures

See a number that looks wrong?